Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral Agents”

1,204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,204 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Testing effectiveness (Phase 2)Study completedNCT01528735
What this trial is testing

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 25
Large-scale testing (Phase 3)Looking for participantsNCT06653569
What this trial is testing

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Who this might be right for
Influenza Disease; Flu
Dre Pauline Vetter 484
Large-scale testing (Phase 3)Study completedNCT00002315
What this trial is testing

A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems

Who this might be right for
HIV InfectionsChickenpox
Glaxo Wellcome 400
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)Study completedNCT00398125
What this trial is testing

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV-1 Infection
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT04596839
What this trial is testing

Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)

Who this might be right for
Covid19
Dr. Md. Alimur Reza 60
Not applicableNot Yet RecruitingNCT05705141
What this trial is testing

The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Not applicableUnknownNCT03687229
What this trial is testing

The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 60
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableUnknownNCT00002301
What this trial is testing

Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Astra USA
Post-approval studies (Phase 4)Study completedNCT04141930
What this trial is testing

Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle

Who this might be right for
InfluenzaRespiratory Viral Infection
University of Washington 481
Testing effectiveness (Phase 2)UnknownNCT04412395
What this trial is testing

Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease

Who this might be right for
Corona Virus InfectionMiddle East Respiratory Syndrome (MERS)Acute Respiratory Distress Syndrome+3 more
National Research Centre, Egypt 516
Post-approval studies (Phase 4)Study completedNCT01455688
What this trial is testing

Early Antiviral Therapy for Critically Ill HIV Infected Patients

Who this might be right for
HIV Infection
Hospital Nossa Senhora da Conceicao 115
Testing effectiveness (Phase 2)Study completedNCT01672983
What this trial is testing

Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 110
Large-scale testing (Phase 3)Study completedNCT00272779
What this trial is testing

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Who this might be right for
HIV Infections
Bristol-Myers Squibb 1,057
Post-approval studies (Phase 4)Study completedNCT02734173
What this trial is testing

Pilot HCV Direct Acting Antiviral Therapy and Metabolism

Who this might be right for
Hepatitis C
Ottawa Hospital Research Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT00144105
What this trial is testing

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Who this might be right for
HIV Infections
Boehringer Ingelheim 562
Load More Results